Martingale Asset Management L P United Therapeutics Corp Transaction History

Martingale Asset Management L P

$3.87 Billion
Q1 2025

A detailed history of Martingale Asset Management L P transactions in United Therapeutics Corp stock. As of the latest transaction made, Martingale Asset Management L P holds 16,798 shares of UTHR stock, worth $5.08 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

16,798

Previous 34,652 51.52%

Holding current value

$5.08 Million

Previous $12.2 Million 57.65%

% of portfolio

0.13%

Previous 0.31%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$304.42 - $380.78 $5.44 Million - $6.8 Million	-17,854 Reduced 51.52%	16,798 $5.18 Million
Q4 2024 Feb 13, 2025	SELL	$348.66 - $410.0 $854,217 - $1 Million	-2,450 Reduced 6.6%	34,652 $12.2 Million
Q3 2024 Nov 14, 2024	SELL	$311.04 - $363.55 $1.76 Million - $2.06 Million	-5,664 Reduced 13.24%	37,102 $13.3 Million
Q2 2024 Aug 12, 2024	SELL	$228.26 - $319.04 $1.26 Million - $1.77 Million	-5,537 Reduced 11.46%	42,766 $13.6 Million
Q1 2024 May 14, 2024	SELL	$210.76 - $249.51 $1.59 Million - $1.88 Million	-7,525 Reduced 13.48%	48,303 $11.1 Million
Q4 2023 Feb 12, 2024	SELL	$214.88 - $256.94 $53,720 - $64,235	-250 Reduced 0.45%	55,828 $12.3 Million
Q3 2023 Nov 14, 2023	SELL	$211.82 - $248.24 $845,161 - $990,477	-3,990 Reduced 6.64%	56,078 $12.7 Million
Q2 2023 Aug 11, 2023	SELL	$205.19 - $232.99 $602,437 - $684,058	-2,936 Reduced 4.66%	60,068 $13.3 Million
Q1 2023 May 12, 2023	BUY	$212.99 - $276.17 $375,075 - $486,335	1,761 Added 2.88%	63,004 $14.1 Million
Q4 2022 Feb 13, 2023	SELL	$205.95 - $280.43 $416,430 - $567,029	-2,022 Reduced 3.2%	61,243 $17 Million
Q3 2022 Nov 14, 2022	BUY	$203.3 - $244.17 $1.65 Million - $1.99 Million	8,140 Added 14.77%	63,265 $13.2 Million
Q2 2022 Aug 11, 2022	BUY	$174.81 - $241.14 $1.1 Million - $1.52 Million	6,307 Added 12.92%	55,125 $13 Million
Q1 2022 May 12, 2022	BUY	$166.16 - $213.96 $2.07 Million - $2.66 Million	12,434 Added 34.17%	48,818 $8.76 Million
Q4 2021 Feb 11, 2022	BUY	$184.32 - $216.08 $5.33 Million - $6.25 Million	28,944 Added 389.03%	36,384 $7.86 Million
Q3 2021 Nov 12, 2021	SELL	$179.86 - $214.88 $14.7 Million - $17.6 Million	-81,937 Reduced 91.68%	7,440 $1.37 Million
Q2 2021 Aug 13, 2021	SELL	$170.47 - $211.93 $1.14 Million - $1.42 Million	-6,694 Reduced 6.97%	89,377 $16 Million
Q1 2021 May 13, 2021	BUY	$153.94 - $174.85 $4.64 Million - $5.27 Million	30,160 Added 45.76%	96,071 $16.1 Million
Q4 2020 Feb 10, 2021	BUY	$101.87 - $151.79 $2.4 Million - $3.58 Million	23,602 Added 55.78%	65,911 $10 Million
Q3 2020 Nov 12, 2020	BUY	$99.9 - $121.13 $2.79 Million - $3.39 Million	27,976 Added 195.19%	42,309 $4.27 Million
Q2 2020 Aug 10, 2020	BUY	$92.74 - $125.82 $1.33 Million - $1.8 Million	14,333 New	14,333 $1.73 Million

Others Institutions Holding UTHR

# of Institutions

734

Shares Held

43.3M

Call Options Held

125K

Put Options Held

124K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $13.8B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Martingale Asset Management L P with notifications on news.

Account

Martingale Asset Management L P United Therapeutics Corp Transaction History